Actively Recruiting
Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study
Led by Swiss Paraplegic Research, Nottwil · Updated on 2025-08-03
24
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
There is a knowledge gap about the influence of the menstrual cycle on bladder function in women with spinal cord injury. So far, studies regarding urinary incontinence have primarily focused on women after menopause. It has become clear that a lack of the sex hormone estrogen, which occurs after menopause, can lead to urinary incontinence. During the course of the menstrual cycle, women also experience fluctuations in their sex hormones, particularly estrogen. The estrogen level is highest before ovulation and decreases afterwards. The investigators aim to explore whether this drop in hormone levels could lead to more frequent urinary incontinence during this phase. In order to offer the patients optimal treatment for urinary incontinence, it is important to understand the potential causes behind it. Participants will document their menstrual cycles and episodes of urinary incontinences over three menstrual cycles using a diary, and urine tests. This research project is a pilot study and is being conducted by Swiss Paraplegic Research at the Swiss Paraplegic Centre. The investigators are recruiting 12 participants who experience incontinence at least once a month and 12 participants who experience incontinence less frequently or not at all.
CONDITIONS
Official Title
Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women
- Age 18 years or older
- Chronic neurogenic bladder dysfunction due to acquired spinal cord injury
- Regular menstrual cycle lasting 26 to 30 days
- Written consent given
- For urinary incontinence group: incontinence at least once per month
You will not qualify if you...
- Detrusor overactivity in storage phase above 15 cmH2O
- Infrequent or absent menstrual periods (oligomenorrhea or amenorrhea)
- Hormonal intake or contraception
- Intake of androgens
- Use of drugs significantly interfering with female sex hormones
- History of sex reassignment surgery
- Pregnant or breastfeeding women
- Women trying to conceive
- Gynecological cancer
- Endometriosis
- Ovariectomy
- Current pelvic floor physiotherapy
- Reconstructive bladder surgery
- Local bladder irritation such as bladder tumor, stones, or acute urinary tract infection at study start
- Inability to follow study procedures due to cognitive or language barriers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Swiss Paraplegic Center
Nottwil, Switzerland, 6207
Actively Recruiting
Research Team
J
Jörg Krebs, Dr. med. vet. / PhD
CONTACT
J
Jürgen Pannek, Prof. Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here